Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Announcement under Regulation 30 (LODR)-Change in Directorate

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE ·

We are submitting the Company''s reply to queries raised by BSE Limited for the Corporate Announcement of the Company submitted on 2nd May 2025 pertaining to resignation of Mr. Sachin Mehta as Chief Financial Officer and appointment of Mr. Manoj Lodha as Chief Financial Officer of the Company, effective 1st May, 2025. Request you to take the same on record.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases